Literature DB >> 23992406

Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).

Liesbeth M Kager1, Tassili A Weehuizen, W Joost Wiersinga, Joris J T H Roelofs, Joost C M Meijers, Arjen M Dondorp, Cornelis van 't Veer, Tom van der Poll.   

Abstract

RATIONALE: α2-Antiplasmin (A2AP) is a major inhibitor of fibrinolysis by virtue of its capacity to inhibit plasmin. Although the fibrinolytic system is strongly affected by infection, the functional role of A2AP in the host response to sepsis is unknown.
OBJECTIVES: To study the role of A2AP in melioidosis, a common form of community-acquired sepsis in Southeast Asia and Northern Australia caused by the gram-negative bacterium Burkholderia pseudomallei.
METHODS: In a single-center observational study A2AP was measured in patients with culture-proven septic melioidosis. Wild-type and A2AP-deficient (A2AP(-/-)) mice were intranasally infected with B. pseudomallei to induce severe pneumosepsis (melioidosis). Parameters of inflammation and coagulation were measured, and survival studies were performed.
MEASUREMENTS AND MAIN RESULTS: Patients with melioidosis showed elevated A2AP plasma levels. Likewise, A2AP levels in plasma and lung homogenates were elevated in mice infected with B. pseudomallei. A2AP-deficient (A2AP(-/-)) mice had a strongly disturbed host response during experimental melioidosis as reflected by enhanced bacterial growth at the primary site of infection accompanied by increased dissemination to distant organs. In addition, A2AP(-/-) mice showed more severe lung pathology and injury together with an increased accumulation of neutrophils and higher cytokine levels in lung tissue. A2AP deficiency further was associated with exaggerated systemic inflammation and coagulation, increased distant organ injury, and enhanced lethality.
CONCLUSIONS: This study is the first to identify A2AP as a protective mediator during gram-negative (pneumo)sepsis by limiting bacterial growth, inflammation, tissue injury, and coagulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23992406     DOI: 10.1164/rccm.201307-1344OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.

Authors:  Justin L Eddy; Jay A Schroeder; Daniel L Zimbler; Lauren E Bellows; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

Review 3.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

Review 4.  Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective.

Authors:  Maiara Marx Luz Fiusa; Marco Antonio Carvalho-Filho; Joyce M Annichino-Bizzacchi; Erich V De Paula
Journal:  BMC Med       Date:  2015-05-06       Impact factor: 8.775

5.  A thrombomodulin mutation that impairs active protein C generation is detrimental in severe pneumonia-derived gram-negative sepsis (melioidosis).

Authors:  Liesbeth M Kager; W Joost Wiersinga; Joris J T H Roelofs; Onno J de Boer; Hartmut Weiler; Cornelis van 't Veer; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

6.  The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.

Authors:  Tim J Schuijt; Jacqueline M Lankelma; Brendon P Scicluna; Felipe de Sousa e Melo; Joris J T H Roelofs; J Daan de Boer; Arjan J Hoogendijk; Regina de Beer; Alex de Vos; Clara Belzer; Willem M de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Gut       Date:  2015-10-28       Impact factor: 23.059

7.  α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.

Authors:  Yosuke Kanno; En Shu; Hiroyuki Kanoh; Ayaka Matsuda; Mariko Seishima
Journal:  Arthritis Res Ther       Date:  2017-02-03       Impact factor: 5.156

8.  Identification of key genes in Gram‑positive and Gram‑negative sepsis using stochastic perturbation.

Authors:  Zhenliang Li; Ying Zhang; Yaling Liu; Yanchun Liu; Youyi Li
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

9.  Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.

Authors:  Jacqueline M Lankelma; Alex Wagemakers; Emma Birnie; Bastiaan W Haak; Jos J A Trentelman; Tassili A F Weehuizen; Jasmin Ersöz; Joris J T H Roelofs; Joppe W Hovius; W Joost Wiersinga; Adriaan D Bins
Journal:  Virulence       Date:  2017-04-19       Impact factor: 5.882

Review 10.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.